• Merck KGaA, Darmstadt, Germany’s decision to enter regulatory development with drug candidate triggers first development milestone • Candidate will
Paris, January 7th, 2020 – PKvitality, a French company specialized in bio wearables, has signed an agreement with Beurer GmBH,
Paris, December 04, 2019 – PKvitality, a French company specialized in bio wearables, was awarded first position in Medtech category
Paris, November 6th, 2019 – Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including
Archamps, 3rd June 2019 – TransCure bioServices (France), a one-stop-shop preclinical services company dedicated to in-vivo full human immune system mouse models, today announced
Paris, October 16, 2018 – Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including
– SoniVie Acquires New Intellectual Property and Other Assets from Cardiosonic Moving TIVUS into New Therapeutic Areas Beyond Pulmonary Hypertension
French-Canadian biotech company has nominated DT-9081 as development candidate and launched CMC activities • DT-9081 will be combined with immune
PKvitality wins the 12th edition of the Healthcare Innovation World Cup
Paris, November 23, 2020 – PKvitality, a French company specialized in bio wearables, has been rewarded by being named the
Latest Insights
Paris, July 22, 2021 – Acticor Biotech, a clinical stage biotechnology company developing an innovative drug for the acute phase
Paris, February 7th 2017 – Acticor Biotech, a biotechnology company focused on the treatment of acute ischemic stroke, today announced that
Paris, France, July 10, 2017 – The European Investment Bank (EIB) and Cellnovo Group (“Cellnovo” or the “Company” CLNV:EN Paris), a
Paris, December 04, 2019 – PKvitality, a French company specialized in bio wearables, was awarded first position in Medtech category
Paris, July 17, 2018, 18h00 CET – EOS imaging (Euronext, FR0011191766 – EOSI), the pioneer of orthopedicmedical imaging 2D / 3D,